About this event

  • Date and time Mon 18 Jan 2021 from 7:00pm to 8:00pm
  • Location Online
  • Organised by Students

Dr Robin Carhart-Harris, Head of Centre for Psychedelic Research, Imperial College London, joins the RSM Students Section for the first episode of the new webinar series, 'An evening with'.

Dr Carhart-Harris has worked extensively within the field of psychedelic research and is part of the team at Imperial College London conducting pioneering clinical trials. He will join a Student Council member of the RSM to speak about his research, motivations and challenges. Discover more about the emerging role of psychedelics in medicine, the current status of clinical trials and the interaction between clinical research and public policy, and pose your own questions to Dr Carhart-Harris in this fascinating live interview. 

An evening with offers a unique platform for medical students to interview preeminent figures in a field they are passionate about. Each episode will explore a different topic, allowing an intimate insight into the inner workings of a pioneer in the field.

Join in the conversation online using #RSMLive

Follow us on Twitter: @RoySocMed

Registration for this webinar will close 2 hours prior to the start time. You will receive the webinar link 2 hours before the meeting. Late registrations will not be accepted.

Key speakers

Dr Robin Carhart-Harris

Dr Robin Carhart-Harris

Head of Centre for Psychedelic Research, Imperial College London

Speaker's biography

Dr Robin Carhart-Harris has worked extensively within the field of psychedelic research and is part of the team at Imperial College London conducting pioneering clinical trials.

 

Dr Carhart-Harris moved to Imperial College London in 2008 after obtaining a PhD in Psychopharmacology from the University of Bristol and an MA in Psychoanalysis from Brunel University.

 

At Imperial, Robin has designed and completed human brain imaging studies with LSD, psilocybin, MDMA and DMT, a clinical trial of psilocybin for treatment-resistant depression, a double-blind randomised controlled trial comparing psilocybin with escitalopram for major depressive disorder and a multimodal imaging study in healthy volunteers receiving psilocybin for the first time.

 

Robin founded the Centre for Psychedelic Research at Imperial College London in April 2019, the first of its kind in the world.

 

He is an experienced speaker with the skills to inspire the audience to learn more about this fascinating topic. Through his role, Dr Carhart-Harris has knowledge of the interaction between science, politics and public policy.

Agenda

View the programme

Welcome and introduction
An evening with Dr Robin Carhart-Harris
Question and answer session
Close of meeting

Location

Online

Disclaimer: All views expressed in this webinar are of the speakers themselves and not of the RSM nor the speaker's organisations. 

Special rates for difficult times
The RSM wishes to offer healthcare professionals continued learning opportunities during the coronavirus pandemic. The RSM’s weekly COVID-19 Series webinars remain free of charge, while there will be small charges to register for other online education. These fees will enable the RSM to continue its programme of activities and will apply during the course of the pandemic.

Registration for this webinar will close 2 hours prior to the start time. You will receive the webinar link 2 hours before the meeting. Late registrations will not be accepted.

All webinars will be available for registered delegates 30 days after on Zoom. The link will be sent 24 hours after the webinar takes place. 

This webinar will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels. 

Man searching computer

Join the RSM and get free access to digital learning resources

The RSM has an extensive digital learning and online e-resources platform. As a member you'll enjoy free access to a wealth of online  resources, including 5,000 subscription and open access e-journals, 2,000 e-books and 5 key medical databases, to support your clinical decision-making and research.

Become a member